Oleksandr Doskalchuk has yet to make his UFC debut and after a failed out of competition drug test, it is going to be another year-plus before the fighter steps into the Octagon.
That’s because has been suspended by the United States Anti-Doping Agency (USADA) for failing an out of competition drug test on June 6 of 2020. Doskalchuk failed the drug test after such prohibited substances like mesterolone metabolites 1α-methyl-5α-androstan-3α-ol-17-one, 1α-methyl-5α-androstan-3α,17β-diol and 1α-methyl-5α-androstan-3,6,16-triol-17-one were found in his urine sample.
The suspension is retroactive to the date of the drug test failure, so Doskalchuk can compete again on August 6 of 2021.
USADA issued the following press release on the matter:
Oleksandr Doskalchuk Accepts Sanction for Violation of UFC Anti-Doping Policy
USADA announced today that Oleksandr Doskalchuk, of Irpin, Ukraine, has accepted a 14-month sanction for a violation of the UFC Anti-Doping Policy.
Doskalchuk, 30, tested positive for the mesterolone metabolites 1α-methyl-5α-androstan-3α-ol-17-one, 1α-methyl-5α-androstan-3α,17β-diol and 1α-methyl-5α-androstan-3,6,16-triol-17-one as the result of a urine sample collected out-of-competition on June 6, 2020. Mesterolone is a non-Specified Substance in the class of Anabolic Agents and is prohibited at all times under the UFC Anti-Doping Policy and UFC Prohibited List.
During an investigation into the circumstances of the case, Doskalchuk provided evidence that a physician incorrectly prescribed him a prohibited medication containing mesterolone despite the fact that Doskalchuk sent him the UFC Wallet Card and requested treatment permitted under the rules. As such, USADA determined that Doskalchuk’s degree of fault was diminished and that he should receive a reduced period of ineligibility.
Doskalchuk received an additional reduction to the otherwise applicable period of ineligibility for his Full and Complete Cooperation. Under the revised UFC ADP announced on November 25, 2019, a Full and Complete Cooperation reduction may be granted in the event that an athlete demonstrates that they did not intend to enhance their performance and provided full, prompt, and truthful responses and information to all reasonable inquiries and requests for information.
Doskalchuk’s 14-month period of ineligibility began on June 6, 2020, the date his positive sample was collected.
USADA conducts the year-round, independent anti-doping program for all UFC athletes. USADA is an independent, non-profit, non-governmental agency whose sole mission is to preserve the integrity of competition, inspire true sport, and protect the rights of clean athletes. In an effort to aid UFC athletes, as well as their support team members, in understanding the rules applicable to them, USADA provides comprehensive instruction on the UFC Anti-Doping Program website (https:// UFC.USADA.org) regarding the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.
In addition, the agency manages a drug reference hotline, Drug Reference Online (https://UFC.GlobalDRO.com), conducts educational sessions, and proactively distributes a multitude of educational materials, such as the Prohibited List, easy-reference wallet cards, and periodic athlete alerts. Many of the resources available to athletes are provided in multiple languages, including Russian, Spanish, French, Portuguese, Korean, and Japanese.
Along with education and testing, robust anti-doping programs enable investigations stemming from tips and whistleblowers. USADA makes available a number of ways to report the abuse of performance-enhancing drugs in sport in an effort to protect clean athletes and promote clean competition. Any tip can be reported using the USADA Play Clean Tip Center, by email at playclean @usada.org, by phone at 1 877-Play Clean (1-877-752-9253), or by mail.